Cargando…
Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations
Understanding the properties of human leukocyte antigen (HLA) peptides (immunopeptides) is essential for precision cancer medicine, while the direct identification of immunopeptides from small biopsies of clinical tissues by mass spectrometry (MS) is still confronted with technical challenges. Here,...
Autores principales: | Minegishi, Yuriko, Kiyotani, Kazuma, Nemoto, Kensaku, Inoue, Yoshikage, Haga, Yoshimi, Fujii, Risa, Saichi, Naomi, Nagayama, Satoshi, Ueda, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388627/ https://www.ncbi.nlm.nih.gov/pubmed/35982173 http://dx.doi.org/10.1038/s42003-022-03807-w |
Ejemplares similares
-
Identification of T Cell Receptors Targeting a Neoantigen Derived from Recurrently Mutated FGFR3
por: Tate, Tomohiro, et al.
Publicado: (2023) -
Fast and Ultrasensitive Glycoform Analysis by Supercritical
Fluid Chromatography–Tandem Mass Spectrometry
por: Haga, Yoshimi, et al.
Publicado: (2022) -
Frontiers in mass spectrometry–based clinical proteomics for cancer diagnosis and treatment
por: Haga, Yoshimi, et al.
Publicado: (2023) -
An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens
por: Olsson, Niclas, et al.
Publicado: (2021) -
Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens
por: Kiyotani, Kazuma, et al.
Publicado: (2018)